|
|
Effect analysis of Bacillus Cereus Live Bacteria Tablets in the adjuvant drug therapy of pregnant patients with acute diarrhea |
ZHANG Zi-cheng1 QIU Wen-fang1 DAI Juan2 CHEN Ya-li1 LIFang-ji1 LIU Ju-ying1 |
1.Department of Internal Medicine,Ganzhou Maternal and Child Health Hospital,Jiangxi Province,Ganzhou 341000,China;
2.Ganzhou Meinian Grand Health Examination Center,Jiangxi Province,Ganzhou 341000,China |
|
|
Abstract Objective To explore the clinical effect of Bacillus Cereus Live Bacteria Tablets in the adjuvant drug therapy of pregnancy patients with acute diarrhea.Methods A total of 60 pregnant women with acute diarrhea treated in the Department of Internal Medicine of Ganzhou Maternal and Child Health Hospital from November 2018 to October 2019 were selected as the research objects,and they were divided into control group(30 cases)and study group(30 cases)by random comprehensive balance method.The patients in the control group were treated with Montmorillonite Powder and the patients in the study group were treated with Montmorillonite Powder combined Bacillus Cereus Live Bacteria Tablets.Patients in both groups were treated for 5 d.The clinical efficacy,number of feces,symptom disappearance time and total adverse reaction rate of the two groups were compared.Results The total effective rate of clinical treatment in the study group was higher than that in the control group,the number of feces in the study group was less than that in the control group,the time of vomiting,abdominal pain disappearance and normal fecal routine time in the study group were shorter than those in the control group,the differences were statistically significant(P<0.05).There was no significant difference in the total incidence of adverse reactions between the two groups (P>0.05).Conclusion According to the symptoms of pregnancy combined with acute diarrhea,the application of Bacillus Cereus Live Bacteria Tablets combined with Montmorillonite powder has a significant clinical effect,which can not only reduce the frequency of defecation,but also shorten the time of vomiting,abdominal pain disappearance and fecal routine time,strong security,which is worth popularizing.
|
Received: 31 March 2020
|
|
|
|
[1] |
刘方旭,许乐.双歧杆菌四联活菌片治疗迁延性、慢性腹泻的随机对照临床研究[J].中华消化杂志,2016,36(12):822-825.
|
[2] |
王秋爽.双歧杆菌、肠球菌、乳杆菌和芽孢杆菌四联活菌肠溶胶囊治疗慢性腹泻的效果分析[J].中国医药指南,2016,14(24):168-169.
|
[3] |
左光熙.双歧杆菌四联活菌在腹泻型肠易激综合征治疗中的应用效果及对血清5-羟色胺、P物质的影响[J].国际医药卫生导报,2019,25(4):652-655.
|
[4] |
焦仕林,朱培蕾,姜朴,等.蜡样芽孢杆菌还原六价铬效果分析[J].中国公共卫生,2016,32(10):1326-1329.
|
[5] |
曾弘华.凝结芽孢杆菌治疗小儿腹泻的疗效[J].实用临床医学,2016,17(4):51-52.
|
[6] |
周志敏.肺炎继发抗菌药物相关性腹泻患儿粪便病原体分布及危险因素分析[J].检验医学与临床,2016,13(16):2380-2382.
|
[7] |
陈良.阿普唑仑联合治疗腹泻型肠易激综合征的疗效[J].西南国防医药,2016,26(5):557-559.
|
[8] |
宋增福,陈彪,郭婧,等.具有群体感应抑制作用的地衣芽孢杆菌T-1的动物安全及生态评价[J].水产学报,2015,39(9):1395-1404.
|
[9] |
张丽霞,沈华祥,曹云飞,等.小麦纤维素颗粒联合凝结芽孢杆菌活菌片治疗晚期妊娠便秘的临床观察[J].中国微生态学杂志,2016,28(11):1333-1336.
|
[10] |
卓奇峰,陈明良,忻畅,等.凝结芽孢杆菌活菌片联合蒙脱石散治疗腹腔镜胆囊切除术后腹泻的临床观察[J].中华全科医学,2019,17(3):379-383.
|
[11] |
陈娟,康靖东,伍东升.美沙拉嗪联合地衣芽孢杆菌活菌治疗溃疡性结肠炎的效果观察[J].中国医药,2016,11(12):1804-1807.
|
[12] |
杨劲,田小莉,刘厚林.凝结芽孢杆菌治疗小儿腹泻的临床效果[J].世界临床医学,2017,11(7):147.
|
[13] |
宋亚玲,张莉,王宜青.蒙脱石散联合金双歧片治疗小儿急性腹泻的效果观察[J].母婴世界,2016,37(3):194-195.
|
[14] |
巫慧敏,翟洋.布拉酵母菌联合蒙脱石散治疗小儿急性腹泻疗效观察[J].医学信息,2015,28(50):76-77.
|
[15] |
郭利涛,孙婧婧,张蕾,等.重症患者抗菌药物相关性腹泻影响因素分析[J].中华医院感染学杂志,2019,29(5):661-664.
|
[16] |
李雅婷,叶建中,吴文瑞,等.蜡样芽孢杆菌通过改变肠道菌群减轻半乳糖胺诱导的Sprague-Dawley大鼠急性肝衰竭[C].第十届全国疑难及重症肝病大会.第十届全国疑难及重症肝病大会论文汇编,2019.
|
[17] |
黄佳,汤玉茗,姚玮艳.伴腹泻炎症性肠病患者感染难辨梭状芽孢杆菌的相关因素及其对短期预后的影响[J].中华消化杂志,2019,39(5):327-331.
|
[18] |
裴敏.蜡样芽孢杆菌胶囊联合蒙脱石散治疗小儿腹泻临床价值[J].药品评价,2018,15(4):50-52.
|
|
|
|